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Summary.-Thenitro-aromatic radiosensitizingdrugsareselectivelytoxic tohypoxic
mammalian cells, and this toxicity can be greatly increased by the addition of
ascorbate. The ascorbate itself is not toxic to either hypoxic or aerobic cells (as long
as catalase is present to prevent the formation of significant concentrations of hydro-
gen peroxide) and the mixture of ascorbate plus radiosensitizer is not more toxic to
aerobic cells.
Sulphydryl reducing agents and dithionite have an effect opposite to ascorbate and
decrease the toxicity of nitro-aromatic drugs under hypoxic conditions. Sulphydryl
reducing agents are also reported to nullify the radiosensitizing properties of nitro-
aromatic drugs, in contrast to ascorbate which has no effect on the radiosensitizing
properties.
The toxicity of nitro-aromatic drugs decreases rapidly with increasing 02 con-
centration. This decrease is much less rapid when ascorbate is present. The role of
ascorbate in this case may be primarily as an 02 scavenger, although it is also possible
that the toxic species produced by radiosensitizer-ascorbate mixtures is less easily
removed or detoxified by 02
A MIAJOR GOAL of radiobiology in the
past few years has been to eliminate
tumour cells which are resistant to con-
ventional treatment. The hypoxic cell
is very resistant to radiation and perhaps
chemicals as well (since it may be isolated
from the blood supply) and a major effort
has been undertaken to find chemicals
or techniques which might sensitize these
cells (hyperbaric 02, hyperthermia,
hypoxic-cell radiosensitizing agents). The
last method is concerned almost exclu-
sively with nitro-aromatic compounds
(Adams & Cooke, 1969; Chapman et al.,
1974), although other oxidizing agents
have also been considered (Koch and
Biaglow, 1 978a; for review see Mitchell
& Marrian, 1965).
In addition to their radiosensitizing
properties, the selective killing of hypoxic
cells by these oxidizing agents is now
clearly established (Sutherland, 1974;
Mohindra & Rauth, 1976; Sridhar et al.,
1976; Koch & Biaglow, 1978a). This
cytotoxicity has been enhanced by ascor-
bate (ASC) (misonidazole (MIS) and ASC;
Josephy et al., 1978), hyperthermia (MIS
and heat; Sridhar & Sutherland, 1977;
Stratford & Adams, 1977; Hall et al., 1977)
and serum (Stratford & Gray, 1978),
but diminished by 02 (Mohindra & Rauth,
1976; Koch & Biaglow, 1978a; Stratford,
1978) and sulphydryl agents (Hall et al.,
1977). The opposite effects of reducing
agents (ASC enhances, sulphydryls such
as glutathione, cysteine, cysteamine and
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mercaptoethanol (RSH) diminish) are
as yet unexplained. Similarly, the reduc-
tion in drug-induced killing by low con-
centrations of 02 (Mohindra & Rauth,
1976; Koch & Biaglow, 1978a; Stratford,
1978) has not been explained, although
it is thought that 02 may accept electrons
from potentially damaging specieswiththe
resultant oxygen radicals being detoxified
by catalase and superoxide dismutase
(Biaglow et al., 1976; Biaglow et al., 1978).
Because of this effect of small amounts
of 02, it is remarkable that killing of
hypoxic cells in vivo (Brown, 1977) and
in multicell spheroids (Sridhar et al.,
1976) by MIS has been found. In both
of these cases one might expect far
more hypoxic than anoxic cells and hence
little killing. In mouse tumours, one would
imagine even less chance of any cytotoxic
effects, because of the short half-life of
MIS in the serum (about 1 h; Rauth et al.,
1978) particularly since there always
appears to be an initial period ofresistance
to the cytotoxicity of these compounds
(Sridhar et al., 1976; Hall et al., 1977;
Stratford & Gray, 1978; and in this
paper).
In this report, we present additional
data on the synergistic toxicities of ASC
in combination with nitro-aromatic drugs,
in the presence or absence of small
amounts of 02. The bulk of the data in
this report concerns the drug MIS which
is currently undergoing clinical trials as a
hypoxic-cell radio-sensitizing agent.
MATERIALS AND METHODS
Most of the experiments used V79 Chinese
hamster cells, designated W3. Some experi-
ments were also carried out with the EMT6
cell line, to help ensure that the results were
not cell-line specific. Both cell lines were
transferred twice weekly in BME (Hanks'
saline) containing 13% (v/v) foetal bovine
serum, and the cells were kept in culture for
up to 12 months before replacement from
frozen stock. Cells were tested and found
free of mycoplasma every 2 months. The
method used was a modification of that
developed by Schneider et al. (1974).
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FIG. 1-Cross section of sealable chambers
used in experiments. The chamber is made
from cast aluminium in 3 parts. The top
and bottom (CT, CB) fit into the middle
(CM) and a seal is made against the two "0"
rings. The exterior and "O"-ring contact
surfaces are anodized to prevent corrosion
when the chambers sit for extended periods
in water baths. The interior anodizing is
machined offsince A1203 is very porous and
retains a great deal ofresidual gas. Connec-
tions aremade tothegassupplyandvacuum
pump manifold (Koch & Painter, 1975)
via C2, V, C1 and MQC (Swagelok 0-seal
straight thread adaptor, Nupro bellows
valve, Cajon forged T [with one arm of T
removed and sealed], and Swagelok male
quick connect [double end shut off]
respectively). S's denote conventional i in
Swagelok connections. The top and bottom
of the chamber can be secured to the
middle section by 4-40 nylon screws, but
it is far more convenient to leave a slight
residual negative pressure to keep the
chamber tightly sealed. Drawing is to
scale except for CM which is really 19 cm
long. Details of valve and quick-connect
interiors, and Swagelok fittings are not
shown.
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The day before an experiment, 2 x105
exponentially growing cells were inoculated
on to glass Petri dishes (50 mm, Pyrex,
Corning). The next day, the medium was
aspirated from the dishes and 2-5 ml of
freshly prepared drug-containing medium
was added to each dish at room temperature.
The dishes were placed in air-tight aluminium
chambers (Fig. 1) and the gas inside was
replaced by either 95% N2+5% CO2 (02
<5 pts/106) or 94.8% N2+5% C02+0-2%
02, in a series of gas changes taking 4-5 h
(Koch & Painter, 1975). Duringthisdeoxygen-
ating procedure the chambers were kept at
0°C. All drugs tested were completely non-
toxic at 0°C, andthedeoxygenating procedure
did not reduce the plating efficiency (typically
80%). For control points, which were to be
incubated withdrug-containingmediuminair,
95% air+5% CO2 was added at the 4 h point
of the degassing procedure (Koch etal., 1977).
The auto-oxidation of ascorbate (or other
reducing agents) leads to the production of
hydrogen peroxide, which is very toxic. To
prevent this toxicity, catalase was added
(Fungal, A. niger-Calbiochem, 9440 u/mg)
at a concentration of 50 u/ml of medium
(Peterkofsky & Prather, 1977; Koch &
Biaglow, 1978a). The catalase had no other
detectable effects and was used in all plates
of all experiments to maintain uniformity.
The chambers were then placed in a water
bath at 37°C for the desired time, after which
they were opened. The dishes were rinsed
with trypsin (GIBCO, 0-05%), and the cells
removed from the dish by incubation in
1 ml of trypsin for 10 min. The cells were
counted and plated in appropriate numbers
on dishes containing 5 ml of BME. These
dishes were incubated for one week and
survival was assayed by counting colonies
of more than 50 cells. Data were plotted as a
fraction of the control plating efficiency
(i.e. dishes which were deoxygenated at
0°C and plated immediately) which was
typically 80%.
In some experiments the cells were irra-
diated by placing the chambers on a rotating
platform in the field of a 60Co y-ray unit,
at a dose rate of --280 rad/min (Koch et al.,
1977). The dose rate was determined by
TLD measurements on plastic dishes, with
glass backscatter assayed by determining the
dose correction factor to achieve the same
survival on glass as in plastic (this correction
was 1-05).
Chemical measurements of the rate of
oxidation ofascorbate were made by monitor-
ing the fall of 02 concentration with time,
using a polarographic 02 electrode in a sealed
vesselwhich wasstirredconstantly. Thevessel
was airtight except for a tiny capillary
opening through which one could admit
various reagents by means of a micro syringe
(Biaglow etal., 1976; Koch & Biaglow, 1978b).
RESULTS
The basic feature of the cytotoxicity
of these drugs is an initial 1-2 h period
of resistance followed by an exponential
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FIG. 2-Cytotoxicity ofradiosensitizers in the
presence or absence of5 mmASC under con-
ditions of extreme hypoxia at 370C.
A 2 mM MIS; * 2 mM MIS+5 mM ASC;
O 20,4M NF-167; 0 20 M NF-167+
5mMASC; D 15mMMET; * 15mmMET
+5 mm ASC. There was no cytotoxicity of
any drug combination in air at 37°C, or in
N2 at 00C. Survival at 1 h for all drugs
was not significantly different from con-
trols, and the points have been omitted
for clarity. All cytotoxicity data shown
are for V79 cells. The chambers reach
temperature equilibrium abouit 15 min
after immersion in the water bath, and
the time scale was corrected for this.
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FIG. 3 Detailed cytotoxicity experiment
comparing the cytotoxicity of 5 mm MIS
in the presence (*, Gl) or absence (*, 0)
of 5 mm ASC. Solid symbols represent
independent duplicate survival determina-
tions (i.e. separate plates containing drug
in separate chambers) with standard errors
indicated where larger than the symbol.
Open symbols represent single survival
determination. Eachdeterminationinvolves
the plating of 4 plates for colony forma-
tion at the appropriate time in the experi-
ment. The times were in increments
of E or 1 h, but some of the initial survival
points have been slightly displaced for
clarity. The best-fit curves for the expo-
nential parts of the data cannot be fitted
to a common extrapolation number, where-
as the time along the initial resistant part
of the cytotoxicity is almost constant
Non-drug controls (-, A).
C (H)
decrease in survival with time (Fig. 2).
For metronidazole (MET), MIS and the
nitrofuran 5-nitro-2-furaldehyde 5-(3-
diethamiono propyl) semioxamazone HC1
(NF-167) ASC appears to potentiate the
toxicity by increasing the slope of the
exponential part of the curve, while
apparently not affecting the initial period
of drug resistance. This is seen more
clearly in an experiment illustrating the
toxicity of 5 mm MIS±5 mm ASC, where
there is practically no killing for 0, 2
and 1 h (Fig. 3).
The potentiation by MIS of the auto-
oxidation ofASC was studied as a function
of concentration of both drugs (Fig. 4a).
At all concentrations studied, MIS en-
hanced the rate of 02 consumption. This
potentiation of auto-oxidation also occurs
in complete medium, and the amount of
potentiation is verly similar, although the
overall reaction rates are somewhat dif-
ferent (Fig. 4b).
If drugs like ASC can be successfully
combined with radiosensitizers to increase
their cytotoxicity, it is important that
the combination is not less effective in its
radiosensitizing properties. It is clear
from the results in Fig. 5 that the presence
of ascorbate does not alter the radio-
sensitizing effect ofMIS.
In cytotoxicity experiments of this
type it is critical to know the 02 con-
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FIG. 4a.-Rate of 02 consumption for 3
concentrations of ascorbate (ASC) as a
function ofMIS concentration. The appara-
tus was a Yellow Springs Oxygen Monitor
instrument, which had a test volume of
3 ml (Biaglow et al., 1976). In addition to
the drugs the solution contained 50 mM
Pi buffer, pH 7-4. Reaction temperature
370C.
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FIG. 4b-Rate ofdecrease of 02 concentration
in 50 ml of Eagle's basal medium-+ 13%
serum containing 2 mm ASC ( ) or
2 mM ASC+ 2 mM MIS ( .... . ). Both
reactions are quasi-zero-or(ler with the
presence of MIS approximately doubling
the overall oxidation rate. The medium
containe(l 10 mM HEPES buffer and
reaction temperature was 37 C. Equipment
as in Koch & Biaglow, 1978b.
centration accurately. For example,
2000 pts/106 of 02 (partial pressure) will
barely sensitize hypoxic cells (Elkind
et al., 1965; Koch et al., 1973) but dras-
tically reduces the cytotoxicity of even
a high concentration (8 mM) of MIS (Fig.
6). In the presence of ASC (5 mM) the
same concentration of 02 has much less
protective effect (Fig. 6).
Throughout these experiments, some
variability between experiments was found
for the cytotoxicity of similar concentra-
tions of drug at similar incubation times,
as has been found by Hall & Stratford
(personal communication). We felt that
this might be due to the presence ofvarious
labile serum components which might
potentiate or decrease the effectiveness
ofthe drug, or even bind to it irreversibly.
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Fie. 5 Lack of effect of 5 mm ASC on the
hypoxic-cell radio-sensitization of 2 mAi
MIS. The irradiation was done at room
temperature. O N2 Control; A N2+ 2 mM
MIS; A N2+2 mM MISm5 mM ASC; 0
Air-Control; * Air+5 mm ASC. There
was no protection by ASC of aerobic cells
(0) or hypoxic cells (data not shown).
OER (dose in N2/dose in 02, for same
survival) was 3-2 an(l the SER (dose in
N2/dose in N2+drug, for same survival)
was 2-4, independent of the survival level
used for the calculation (i.e. the drug or
02 has a dose-modifying response).
Therefore we tried various experiments
to test for this. It made no difference
whether the MIS was dissolved in H20,
balanced salt solution or serum, or whether
the mixing solution was sonicated to
hasten solubilization, as long as the final
drug solution inoculated on to the cells
was in complete medium. There was also
no effect of mixing the drug at high con-
centrations and diluting, or mixing the
desired concentration outright. However,
there was an increase in cytotoxicity
when the entire experiment was per-
formed in medium which was either serum-
free or contained heat-inactivated serum,
particularly in the presence of ASC (Fig.
7). In the presence of heat-inactivated
serum one experiment showed toxicity
somewhat greater than without serum,
and in a second experiment the opposite
result was found (data not shown). The
differences were so minor, however, that
this matter was not pursued.
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FIcGT. 6 Effect of small concentrations of 02
on the cytotoxicity of 8 mm MIS in the
presence or absence of 5 mm ASC. [ 8 inm
MIS, moderate hypoxia (0-2% O2, MH);
* 8 mm MIS, extreme hypoxia (EH); 0
8 mM MIS A5 inMASC (MH);O8 mM MIS
+5 mM ASC (EH); 7 8 mm MIS+ 1 mm
ASC (EH); A 2 mM MIS (EH); A 2 mmr
MIS +5 mmu ASC (EH); 0 Josephy et
al. (15 mM MIS+5 mm ASC); x Josephy
et al. (15 mm MIS). Note that moderate
hypoxia (I3) almost completely eliminates
the very large cytotoxicity seen under
extreme hypoxia (*). When 5 mM ASC
is added, there is greatly increased
killing under EH (-) and MH gives much
less protection (0). A single survival
point at 4 h showed that, 1 mM ASC (V)
was just as effective as 5 mar ASC (-)
in potentiating the cytotoxicity of MIS.
The arrow on the 4 h point for 8 mm MIS
+ 5 mM ASC (EH) indicates the maximum
survival as there were no survivors on
these plates. The (data for 2 mm MIS (EH)
without (A) and with (A) 5 mm ASC
shows that the ascorbate has increase(d the
killing by 2 mm MIS to the level seen by
8 mM MIS without ASC. Data from Josephy
et al. (1978) for 15 mm MIS (fitted by eye)
showed more cytotoxicity in the presence
of ASC (0) than our 8 mm data (as expec-
ted) but less cytotoxicity in the absence
of ASC (x) than our 8 mm data. All
experimental conditions were tested at 1 h
but (A and O (100% survival)) were omit-
te(l for clarity.
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FICG. 7 Effect of serum on cytotoxicity of
2 mm MIS in the presence or absence of
5 mm ASC under conditions of extreme
hypoxia at 37°C. * 2 mM MIS+serum;
[D 2mM MIS-serum; A 2mM MIS+
5mM ASC+serum; A 2mM MIS+5mM
ASC- serum. The lower values for MIS+
ASC (A, A) are from an independent
experiment.
One possible labile serum component
is free sulphydryl. In an experiment com-
paring the cytotoxicity of 5 mm MIS in
the presence of ASC and other reducing
agents, only ASC potentiated the damage.
In fact, 5 mm glutathione, cysteamine-
HCI, mercaptoethanol, or cysteine all
protected against the toxicity of 2 mm
TABLE. Test of several reducing agents
on the cytotoxicity of 2 mM MIS (extreme
hypoxia, 37°C, 6 h)
Drug(s)
Control (No drugs)
2 mar MIS
2 mMMIS+5 mm ASC
2 mir MIS + 5 mi%i Glutathione
2 mm MIS+5 mM Cysteamine
2 mM MIS+5 mM Cysteine
2 mm MIS + 5 mii Mercaptoethanol
2 mm MIS+ 2-5 mm Na dithionite
Survival
(%±s.e.)
62-0±3-1
9-8+0-3
1-3±0-1
55-7±1-5
69-0+4-0
58-5 + 3-5
71-0±3-2
72-0±5-0
II II
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MIS. Even dithionite (2.5 mM) diminished
rather than potentiated the toxicity of
2 mm MIS (Table).
DISCUSSION
The results presented here clearly
demonstrate the possible benefits of com-
bined ascorbate-sensitizer with respect
to hypoxic-cell killing in vitro (Figs.
2, 3, 6, 7). The effects of high doses of
ASC in vivo, however, are more difficult
to predict. For example, ASC could on the
one hand increase the cytotoxicity of
radio-sensitizing drugs, but on the other
hand increase the fraction ofhypoxic cells,
through auto-oxidation processes (Fig. 4).
This, in fact, may be the cause of the
increased cytotoxicity seen with ASC-
MIS at a gas-phase 02 partial-pressure of
2000 pts/106 (Fig. 6); in other words,
the auto-oxidation of ascorbate decreases
the concentration of 02 in the medium
below the gas-phase value. However, in
vivo, the rate of cellular 02 consumption
would be about 5 4x 10-2 mol/h [assuming
a cell concentration of 5x108/g and an
02 consumption rate of 5 x 10-17 mol/
cell/sec (Koch & Biaglow, 1978b)]. In
contrast, the auto-oxidation rate of 2 mm
ASC+2 mm MIS in BME is about 500 x
less than this (Fig. 4b). Thus, the auto-
oxidation of vitamin C would not be
expected to change the overall 02 con-
centration significantly, except perhaps
in local areas where the 02 concentration
was already very low.
The contrasting effects of ascorbate
and SH-containing compounds warrant
considerable further investigation. In par-
ticular, combinations of sensitizer, ASC,
and RSH should be tested in the cyto-
toxicity assay. This is essential, to show
which effect predominates (enhancement
of toxicity by ASC, reduction of toxicity
by RSH) and whether there is a chemical
competition between the effects. A sig-
nificant concentration of RSH or RSSR
certainly exists in vivo. One published
report has shown that cysteamine protects
against both the radiosensitizing and
cytotoxic effects at about the same con-
22
centration (Hall et al., 1977). Thus the
fact that significant radiosensitization
has been shown for hypoxic cells in vivo
already suggests that free SH may not be
high enough to be a significant problem
in the use of agents like MIS. In addition
it is necessary to identify the precise
concentrations of ASC or RSH necessary
to achieve full potentiation or decrease
in cytotoxicity. Preliminary evidence
would indicate that 1 mm ASC is just as
effective as 5 mm (Fig. 6).
This points to important differences
between our results and those of Josephy
et al. (1978). Those investigators found a
greater potentiation by ascorbate of the
cytotoxicity of MIS than we did, and in
addition, found a significant dependence
of the cytotoxicity on vitamin C con-
centration. They also found potentiation
ofthe cytotoxicity ofMIS by glutathione.
We believe that these discrepancies can
be explained by incomplete 02 removal
from their test system. This would explain
the relatively smaller amount of toxicity
seen for 5 and 15 mm MIS alone (compared
with other reports-Hall et al, 1977;
Stratford & Adams, 1977; Mohindra &
Rauth, 1976; this paper) because of the
protective effect of 02 (Fig. 6). Thus the
addition of ASC would not only increase
the cytotoxicity, but decrease the 02
concentration (Fig. 6 and see previous
discussion). Finally, the small amount of
potentiation reported by Josephy et al.
for glutathione could also be caused by
auto-oxidation of glutathione, leading to
reduced 02 levels. The protection by RSH
of the cytotoxicity of MIS observed in
our results agrees completely with a
previous report by Hall et al. (1977), who
found that cysteamine not only nullified
the cytotoxicity ofMIS, but also cancelled
its radiosensitizing properties. Our results
show that ASC potentiated the cyto-
toxicity and did not affect the radio-
sensitizing properties of MIS (Fig. 5).
A major problem in the comparison of
the cytotoxic effects of misonidazole in
different laboratories involves traces of
02, and components of serum which are
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as yet unidentified. Thus, Mohindra &
Rauth (1976) and Stratford (1978) have
found that relatively small concentrations
Of 02 can greatly reduce the cytotoxic
effects of radiosensitizers (Fig. 6). Quanti-
tative assessments of this reduction as a
function of 02 concentration have not
yet been made, and may very well depend
on the electron affinity of the drug and
the presence or absence of compounds like
RSH in the medium. Even greater prob-
lems may occur because of the unpredict-
able effects of serum. Thus, Stratford &
Gray (1978) found potentiation of cyto-
toxicity by serum whereas we have found
reduction of cytotoxicity by serum. In
retrospect these differences might be
expected, since the action of reducing
agents like ASC and RSH are opposite.
However, it is ofinterest that the survival
curves (2 mM MIS, extreme hypoxia) for
the V79 cells used by Stratford & Gray
(1978) and for the V79 cells used in our
present experiments are very similar when
no serum is present (compare Fig. 3 of
Stratford paper with Fig. 7 of this paper).
This important internal agreement sug-
gests that the serum effects are real and
that the chemicals responsible should be
identified.
Finally, at the chemical level, we still
do not understand the role of ASC in the
killing of hypoxic cells by agents like
MIS and indeed the toxic species itself
has not been identified. Ifthe toxic species
is the same for both MIS and (MIS+
ASC), ASC is probably acting by increas-
ing the reduction (presumably metabolic)
ofMIS to a more harmful species. Alterna-
tively, the increased toxicity may be
caused by an oxidation product ofvitamin
C (e.g. semi-quinone), whose mode of
action may be similar to that of dehydro-
ascorbic acid (Koch & Biaglow, 1978a).
Our current experiments are aimed at
trying to elucidate the killing mechanisms
for these drugs.
This work was supported by the Ontario Cancer
Treatment & Research Foundation, London Clinic.
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